Given the importance of PPARγ agonists in diabetes therapy, it is fundamental to take into account, however, the deep side effects caused by these drugs, such as oedema, headache, heart failure, hypoglycaemia, myalgias, and increased risk of fractures [51]. This evidence concerns the gene PPARG and diabetes mellitus.